Quantcast

Latest Leukotriene antagonists Stories

2014-03-25 00:23:18

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rq8jml/investigation) has announced the addition of the "Investigation Report on China Montelukast Market" [http://www.researchandmarkets.com/research/rq8jml/investigation ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) There are over 30 million people suffering from seasonal asthma of different...

2011-05-06 07:32:05

(Ivanhoe Newswire) -- A new study shows a rarely-prescribed drug is easier to use and may be just as effective as treatment with inhalers. Asthma affects about 300 million people worldwide. It is a chronic condition characterized by inflammation of the airways that leads to wheezing, coughing, chest tightness and shortness of breath. Researchers followed 650 patients with chronic asthma for two years. They found leukotriene receptor antagonists (LTRAs) were just as successful at managing the...

2011-05-05 13:01:28

A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA). Publishing tomorrow in the New England Journal of Medicine, the researchers followed 650 patients with chronic asthma for two years. They found that tablets called leukotriene receptor antagonists (LTRAs) managed the disease equally successfully as steroid inhalers and other 'preventer' inhalers when used in...

5aaa50e05b1fe6dcd3a041cdcfcda261
2011-05-05 10:25:00

Asthma sufferers are more often prescribed inhalers than pills to treat their symptoms. However, a British study published in the New England Journal of Medicine (NEJM) suggests that pills marketed under brand names such as Singulair and Accolate work just as well and are easier for patients to manage, reports AFP. Led by Professor David Price of the University of Aberdeen and the University of East Anglia, the study followed 650 chronic asthma patients for two years. Two sub-studies were...

2011-05-04 16:00:00

NORWICH, England, May 4, 2011 /PRNewswire/ -- A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA). Publishing tomorrow in the New England Journal of Medicine, the researchers followed 650 patients with chronic asthma for two years. They found that tablets called leukotriene receptor antagonists (LTRAs) managed the disease equally successfully as steroid...

2011-04-27 07:00:00

ST. PAUL, Minn., April 27, 2011 /PRNewswire/ -- Patients with asthma or allergic rhinitis (nasal allergies), initially prescribed montelukast (Singulair®) instead of typical first-line therapy have low rates of persistence on montelukast and may ultimately discontinue therapy altogether, according to a new study presented at the Academy of Managed Care Pharmacy's 23rd Annual Meeting in Minneapolis, Minn. The study will be presented by Prime Therapeutics (Prime), a thought...

2011-03-30 07:33:00

WARREN, N.J., March 30, 2011 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway. The registration dossier of Montelukast Sodium OSF will be primarily...

2009-06-15 12:56:42

The U.S. Food and Drug Administration has asked manufacturers to include a precaution in the labeling of some asthma drugs called leukotriene modifiers. The federal agency said the labeling should advise patients that some neuropsychiatric events have been reported by people taking montelukast (Singulair), zafirlukast (Accolate) and zileuton (Zyflo and Zyflo CR). Leukotrienes are chemicals the body releases in response to an inflammatory stimulus, such as when a person breathes in an...

e99d671308962f6188d1fe1d598bda9b1
2009-06-13 13:50:01

Federal regulators said on Friday new labels on popular asthma drugs like Merck's Singulair must highlight language about suicidal behavior, depression and anxiety seen in a small number of patients, The Associated Press. The Food and Drug Administration said after 15 months of investigation that drug companies Merck & Co. Inc., AstraZeneca and Cornerstone Therapeutics would have to raise label warnings about psychiatric problems reported by a handful of patients that were prescribed the...

2009-01-14 13:27:09

The U.S. Food and Drug Administration said a safety review has yet to find conclusive evidence of any link between certain asthma drugs and suicide. The agency last March announced that it was reviewing data that raised concerns about a possible association between the use of Singulair and behavior/mood changes, suicide, suicidal thinking and suicidal behavior. The FDA has urged both healthcare professionals and patients to report side effects from the use of drugs Singulair, Accolate, Zyflo,...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related